Skip to content

Drug interactions

Dasatinib + Solifenacin

Severity: Moderate

Dasatinib and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dasatinib is a weak CYP3A4 inhibitor and may modestly raise solifenacin exposure. Both drugs can prolong the QT interval, so the combination may increase arrhythmia risk, especially with other risk factors.

What this interaction means in plain words

Dasatinib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dasatinib belongs to Oncology; Solifenacin belongs to Genitourinary.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by dasatinib plus additive QT prolongation.

What to do

Obtain a baseline ECG and correct potassium and magnesium before combining. Monitor the QTc and anticholinergic effects, and limit the solifenacin dose if QT risk is high.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Solifenacin?

MediHelp rates the interaction as moderate. Dasatinib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dasatinib is a weak CYP3A4 inhibitor and may modestly raise solifenacin exposure. Both drugs can prolong the QT interval, so the combination may increase arrhythmia risk, especially with other risk factors.

How serious is the interaction between Dasatinib and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium before combining. Monitor the QTc and anticholinergic effects, and limit the solifenacin dose if QT risk is high.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in